世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および中国の臨床試験におけるCROの市場規模、現状、および予測 2021-2027年


Global and China CRO in Clinical Trials Market Size, Status and Forecast 2021-2027

市場分析とインサイト。臨床試験における世界のCRO市場 臨床試験における世界のCRO市場規模は、2020年のXX百万米ドルから2021-2027年の間にXX%の年率で推移し、2027年にはXX百万米ドルに達すると予測されていま... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2021年12月3日 US$3,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

市場分析とインサイト。臨床試験における世界のCRO市場
臨床試験における世界のCRO市場規模は、2020年のXX百万米ドルから2021-2027年の間にXX%の年率で推移し、2027年にはXX百万米ドルに達すると予測されています。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の臨床試験受託機関(CRO)市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つよう、見事な試みを行っています。本レポートの購入者は、世界の臨床試験受託機関(CRO)市場の全体的な規模(売上高)など、検証済みの信頼できる市場予測にアクセスすることができます。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界の臨床試験受託機関(CRO)市場で永続的な成功を収めるための効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の臨床試験受託機関(CRO)市場を詳細に調査するために、独自の業界最高水準の調査・分析手法を採用しました。

臨床試験におけるグローバルCROの範囲と市場規模
臨床試験におけるCRO市場は、企業別、地域(国)別、タイプ別、アプリケーション別に分類されています。世界のCRO in Clinical Trials市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間におけるタイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
フェーズI試験
フェーズII試験
第III相試験
第4相試験

アプリケーション別セグメント
製薬
バイオ医薬品

地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
U.K.
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
Covance (Lab. Corp.)
QVIA
シネオス・ヘルス
パレクセル
PRAヘルスサイエンス
PPD
チャールズ・リバー
ICON
無錫 AppTec
MedPace


ページTOPに戻る


目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRO in Clinical Trials Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Phase I Trial
1.2.3 Phase II Trial
1.2.4 Phase III Trial
1.2.5 Phase IV Trial
1.3 Market by Application
1.3.1 Global CRO in Clinical Trials Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical
1.3.3 Bio-pharm
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global CRO in Clinical Trials Market Perspective (2016-2027)
2.2 CRO in Clinical Trials Growth Trends by Regions
2.2.1 CRO in Clinical Trials Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 CRO in Clinical Trials Historic Market Share by Regions (2016-2021)
2.2.3 CRO in Clinical Trials Forecasted Market Size by Regions (2022-2027)
2.3 CRO in Clinical Trials Industry Dynamic
2.3.1 CRO in Clinical Trials Market Trends
2.3.2 CRO in Clinical Trials Market Drivers
2.3.3 CRO in Clinical Trials Market Challenges
2.3.4 CRO in Clinical Trials Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top CRO in Clinical Trials Players by Revenue
3.1.1 Global Top CRO in Clinical Trials Players by Revenue (2016-2021)
3.1.2 Global CRO in Clinical Trials Revenue Market Share by Players (2016-2021)
3.2 Global CRO in Clinical Trials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CRO in Clinical Trials Revenue
3.4 Global CRO in Clinical Trials Market Concentration Ratio
3.4.1 Global CRO in Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRO in Clinical Trials Revenue in 2020
3.5 CRO in Clinical Trials Key Players Head office and Area Served
3.6 Key Players CRO in Clinical Trials Product Solution and Service
3.7 Date of Enter into CRO in Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans

4 CRO in Clinical Trials Breakdown Data by Type
4.1 Global CRO in Clinical Trials Historic Market Size by Type (2016-2021)
4.2 Global CRO in Clinical Trials Forecasted Market Size by Type (2022-2027)

5 CRO in Clinical Trials Breakdown Data by Application
5.1 Global CRO in Clinical Trials Historic Market Size by Application (2016-2021)
5.2 Global CRO in Clinical Trials Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America CRO in Clinical Trials Market Size (2016-2027)
6.2 North America CRO in Clinical Trials Market Size by Type
6.2.1 North America CRO in Clinical Trials Market Size by Type (2016-2021)
6.2.2 North America CRO in Clinical Trials Market Size by Type (2022-2027)
6.2.3 North America CRO in Clinical Trials Market Size by Type (2016-2027)
6.3 North America CRO in Clinical Trials Market Size by Application
6.3.1 North America CRO in Clinical Trials Market Size by Application (2016-2021)
6.3.2 North America CRO in Clinical Trials Market Size by Application (2022-2027)
6.3.3 North America CRO in Clinical Trials Market Size by Application (2016-2027)
6.4 North America CRO in Clinical Trials Market Size by Country
6.4.1 North America CRO in Clinical Trials Market Size by Country (2016-2021)
6.4.2 North America CRO in Clinical Trials Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe CRO in Clinical Trials Market Size (2016-2027)
7.2 Europe CRO in Clinical Trials Market Size by Type
7.2.1 Europe CRO in Clinical Trials Market Size by Type (2016-2021)
7.2.2 Europe CRO in Clinical Trials Market Size by Type (2022-2027)
7.2.3 Europe CRO in Clinical Trials Market Size by Type (2016-2027)
7.3 Europe CRO in Clinical Trials Market Size by Application
7.3.1 Europe CRO in Clinical Trials Market Size by Application (2016-2021)
7.3.2 Europe CRO in Clinical Trials Market Size by Application (2022-2027)
7.3.3 Europe CRO in Clinical Trials Market Size by Application (2016-2027)
7.4 Europe CRO in Clinical Trials Market Size by Country
7.4.1 Europe CRO in Clinical Trials Market Size by Country (2016-2021)
7.4.2 Europe CRO in Clinical Trials Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific CRO in Clinical Trials Market Size (2016-2027)
8.2 Asia-Pacific CRO in Clinical Trials Market Size by Type
8.2.1 Asia-Pacific CRO in Clinical Trials Market Size by Type (2016-2021)
8.2.2 Asia-Pacific CRO in Clinical Trials Market Size by Type (2022-2027)
8.2.3 Asia-Pacific CRO in Clinical Trials Market Size by Type (2016-2027)
8.3 Asia-Pacific CRO in Clinical Trials Market Size by Application
8.3.1 Asia-Pacific CRO in Clinical Trials Market Size by Application (2016-2021)
8.3.2 Asia-Pacific CRO in Clinical Trials Market Size by Application (2022-2027)
8.3.3 Asia-Pacific CRO in Clinical Trials Market Size by Application (2016-2027)
8.4 Asia-Pacific CRO in Clinical Trials Market Size by Region
8.4.1 Asia-Pacific CRO in Clinical Trials Market Size by Region (2016-2021)
8.4.2 Asia-Pacific CRO in Clinical Trials Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America CRO in Clinical Trials Market Size (2016-2027)
9.2 Latin America CRO in Clinical Trials Market Size by Type
9.2.1 Latin America CRO in Clinical Trials Market Size by Type (2016-2021)
9.2.2 Latin America CRO in Clinical Trials Market Size by Type (2022-2027)
9.2.3 Latin America CRO in Clinical Trials Market Size by Type (2016-2027)
9.3 Latin America CRO in Clinical Trials Market Size by Application
9.3.1 Latin America CRO in Clinical Trials Market Size by Application (2016-2021)
9.3.2 Latin America CRO in Clinical Trials Market Size by Application (2022-2027)
9.3.3 Latin America CRO in Clinical Trials Market Size by Application (2016-2027)
9.4 Latin America CRO in Clinical Trials Market Size by Country
9.4.1 Latin America CRO in Clinical Trials Market Size by Country (2016-2021)
9.4.2 Latin America CRO in Clinical Trials Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa CRO in Clinical Trials Market Size (2016-2027)
10.2 Middle East & Africa CRO in Clinical Trials Market Size by Type
10.2.1 Middle East & Africa CRO in Clinical Trials Market Size by Type (2016-2021)
10.2.2 Middle East & Africa CRO in Clinical Trials Market Size by Type (2022-2027)
10.2.3 Middle East & Africa CRO in Clinical Trials Market Size by Type (2016-2027)
10.3 Middle East & Africa CRO in Clinical Trials Market Size by Application
10.3.1 Middle East & Africa CRO in Clinical Trials Market Size by Application (2016-2021)
10.3.2 Middle East & Africa CRO in Clinical Trials Market Size by Application (2022-2027)
10.3.3 Middle East & Africa CRO in Clinical Trials Market Size by Application (2016-2027)
10.4 Middle East & Africa CRO in Clinical Trials Market Size by Country
10.4.1 Middle East & Africa CRO in Clinical Trials Market Size by Country (2016-2021)
10.4.2 Middle East & Africa CRO in Clinical Trials Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Covance (Lab. Corp.)
11.1.1 Covance (Lab. Corp.) Company Details
11.1.2 Covance (Lab. Corp.) Business Overview
11.1.3 Covance (Lab. Corp.) CRO in Clinical Trials Introduction
11.1.4 Covance (Lab. Corp.) Revenue in CRO in Clinical Trials Business (2016-2021)
11.1.5 Covance (Lab. Corp.) Recent Development
11.2 QVIA
11.2.1 QVIA Company Details
11.2.2 QVIA Business Overview
11.2.3 QVIA CRO in Clinical Trials Introduction
11.2.4 QVIA Revenue in CRO in Clinical Trials Business (2016-2021)
11.2.5 QVIA Recent Development
11.3 Syneos Health
11.3.1 Syneos Health Company Details
11.3.2 Syneos Health Business Overview
11.3.3 Syneos Health CRO in Clinical Trials Introduction
11.3.4 Syneos Health Revenue in CRO in Clinical Trials Business (2016-2021)
11.3.5 Syneos Health Recent Development
11.4 Parexel
11.4.1 Parexel Company Details
11.4.2 Parexel Business Overview
11.4.3 Parexel CRO in Clinical Trials Introduction
11.4.4 Parexel Revenue in CRO in Clinical Trials Business (2016-2021)
11.4.5 Parexel Recent Development
11.5 PRA Health Sciences
11.5.1 PRA Health Sciences Company Details
11.5.2 PRA Health Sciences Business Overview
11.5.3 PRA Health Sciences CRO in Clinical Trials Introduction
11.5.4 PRA Health Sciences Revenue in CRO in Clinical Trials Business (2016-2021)
11.5.5 PRA Health Sciences Recent Development
11.6 PPD
11.6.1 PPD Company Details
11.6.2 PPD Business Overview
11.6.3 PPD CRO in Clinical Trials Introduction
11.6.4 PPD Revenue in CRO in Clinical Trials Business (2016-2021)
11.6.5 PPD Recent Development
11.7 Charles River
11.7.1 Charles River Company Details
11.7.2 Charles River Business Overview
11.7.3 Charles River CRO in Clinical Trials Introduction
11.7.4 Charles River Revenue in CRO in Clinical Trials Business (2016-2021)
11.7.5 Charles River Recent Development
11.8 ICON
11.8.1 ICON Company Details
11.8.2 ICON Business Overview
11.8.3 ICON CRO in Clinical Trials Introduction
11.8.4 ICON Revenue in CRO in Clinical Trials Business (2016-2021)
11.8.5 ICON Recent Development
11.9 Wuxi AppTec
11.9.1 Wuxi AppTec Company Details
11.9.2 Wuxi AppTec Business Overview
11.9.3 Wuxi AppTec CRO in Clinical Trials Introduction
11.9.4 Wuxi AppTec Revenue in CRO in Clinical Trials Business (2016-2021)
11.9.5 Wuxi AppTec Recent Development
11.10 MedPace
11.10.1 MedPace Company Details
11.10.2 MedPace Business Overview
11.10.3 MedPace CRO in Clinical Trials Introduction
11.10.4 MedPace Revenue in CRO in Clinical Trials Business (2016-2021)
11.10.5 MedPace Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る


 

Summary

Market Analysis and Insights: Global CRO in Clinical Trials Market
The global CRO in Clinical Trials market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CRO in Clinical Trials market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CRO in Clinical Trials market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CRO in Clinical Trials market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CRO in Clinical Trials market.

Global CRO in Clinical Trials Scope and Market Size
CRO in Clinical Trials market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CRO in Clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Phase I Trial
Phase II Trial
Phase III Trial
Phase IV Trial

Segment by Application
Pharmaceutical
Bio-pharm

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Covance (Lab. Corp.)
QVIA
Syneos Health
Parexel
PRA Health Sciences
PPD
Charles River
ICON
Wuxi AppTec
MedPace



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRO in Clinical Trials Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Phase I Trial
1.2.3 Phase II Trial
1.2.4 Phase III Trial
1.2.5 Phase IV Trial
1.3 Market by Application
1.3.1 Global CRO in Clinical Trials Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical
1.3.3 Bio-pharm
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global CRO in Clinical Trials Market Perspective (2016-2027)
2.2 CRO in Clinical Trials Growth Trends by Regions
2.2.1 CRO in Clinical Trials Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 CRO in Clinical Trials Historic Market Share by Regions (2016-2021)
2.2.3 CRO in Clinical Trials Forecasted Market Size by Regions (2022-2027)
2.3 CRO in Clinical Trials Industry Dynamic
2.3.1 CRO in Clinical Trials Market Trends
2.3.2 CRO in Clinical Trials Market Drivers
2.3.3 CRO in Clinical Trials Market Challenges
2.3.4 CRO in Clinical Trials Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top CRO in Clinical Trials Players by Revenue
3.1.1 Global Top CRO in Clinical Trials Players by Revenue (2016-2021)
3.1.2 Global CRO in Clinical Trials Revenue Market Share by Players (2016-2021)
3.2 Global CRO in Clinical Trials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CRO in Clinical Trials Revenue
3.4 Global CRO in Clinical Trials Market Concentration Ratio
3.4.1 Global CRO in Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRO in Clinical Trials Revenue in 2020
3.5 CRO in Clinical Trials Key Players Head office and Area Served
3.6 Key Players CRO in Clinical Trials Product Solution and Service
3.7 Date of Enter into CRO in Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans

4 CRO in Clinical Trials Breakdown Data by Type
4.1 Global CRO in Clinical Trials Historic Market Size by Type (2016-2021)
4.2 Global CRO in Clinical Trials Forecasted Market Size by Type (2022-2027)

5 CRO in Clinical Trials Breakdown Data by Application
5.1 Global CRO in Clinical Trials Historic Market Size by Application (2016-2021)
5.2 Global CRO in Clinical Trials Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America CRO in Clinical Trials Market Size (2016-2027)
6.2 North America CRO in Clinical Trials Market Size by Type
6.2.1 North America CRO in Clinical Trials Market Size by Type (2016-2021)
6.2.2 North America CRO in Clinical Trials Market Size by Type (2022-2027)
6.2.3 North America CRO in Clinical Trials Market Size by Type (2016-2027)
6.3 North America CRO in Clinical Trials Market Size by Application
6.3.1 North America CRO in Clinical Trials Market Size by Application (2016-2021)
6.3.2 North America CRO in Clinical Trials Market Size by Application (2022-2027)
6.3.3 North America CRO in Clinical Trials Market Size by Application (2016-2027)
6.4 North America CRO in Clinical Trials Market Size by Country
6.4.1 North America CRO in Clinical Trials Market Size by Country (2016-2021)
6.4.2 North America CRO in Clinical Trials Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe CRO in Clinical Trials Market Size (2016-2027)
7.2 Europe CRO in Clinical Trials Market Size by Type
7.2.1 Europe CRO in Clinical Trials Market Size by Type (2016-2021)
7.2.2 Europe CRO in Clinical Trials Market Size by Type (2022-2027)
7.2.3 Europe CRO in Clinical Trials Market Size by Type (2016-2027)
7.3 Europe CRO in Clinical Trials Market Size by Application
7.3.1 Europe CRO in Clinical Trials Market Size by Application (2016-2021)
7.3.2 Europe CRO in Clinical Trials Market Size by Application (2022-2027)
7.3.3 Europe CRO in Clinical Trials Market Size by Application (2016-2027)
7.4 Europe CRO in Clinical Trials Market Size by Country
7.4.1 Europe CRO in Clinical Trials Market Size by Country (2016-2021)
7.4.2 Europe CRO in Clinical Trials Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific CRO in Clinical Trials Market Size (2016-2027)
8.2 Asia-Pacific CRO in Clinical Trials Market Size by Type
8.2.1 Asia-Pacific CRO in Clinical Trials Market Size by Type (2016-2021)
8.2.2 Asia-Pacific CRO in Clinical Trials Market Size by Type (2022-2027)
8.2.3 Asia-Pacific CRO in Clinical Trials Market Size by Type (2016-2027)
8.3 Asia-Pacific CRO in Clinical Trials Market Size by Application
8.3.1 Asia-Pacific CRO in Clinical Trials Market Size by Application (2016-2021)
8.3.2 Asia-Pacific CRO in Clinical Trials Market Size by Application (2022-2027)
8.3.3 Asia-Pacific CRO in Clinical Trials Market Size by Application (2016-2027)
8.4 Asia-Pacific CRO in Clinical Trials Market Size by Region
8.4.1 Asia-Pacific CRO in Clinical Trials Market Size by Region (2016-2021)
8.4.2 Asia-Pacific CRO in Clinical Trials Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America CRO in Clinical Trials Market Size (2016-2027)
9.2 Latin America CRO in Clinical Trials Market Size by Type
9.2.1 Latin America CRO in Clinical Trials Market Size by Type (2016-2021)
9.2.2 Latin America CRO in Clinical Trials Market Size by Type (2022-2027)
9.2.3 Latin America CRO in Clinical Trials Market Size by Type (2016-2027)
9.3 Latin America CRO in Clinical Trials Market Size by Application
9.3.1 Latin America CRO in Clinical Trials Market Size by Application (2016-2021)
9.3.2 Latin America CRO in Clinical Trials Market Size by Application (2022-2027)
9.3.3 Latin America CRO in Clinical Trials Market Size by Application (2016-2027)
9.4 Latin America CRO in Clinical Trials Market Size by Country
9.4.1 Latin America CRO in Clinical Trials Market Size by Country (2016-2021)
9.4.2 Latin America CRO in Clinical Trials Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa CRO in Clinical Trials Market Size (2016-2027)
10.2 Middle East & Africa CRO in Clinical Trials Market Size by Type
10.2.1 Middle East & Africa CRO in Clinical Trials Market Size by Type (2016-2021)
10.2.2 Middle East & Africa CRO in Clinical Trials Market Size by Type (2022-2027)
10.2.3 Middle East & Africa CRO in Clinical Trials Market Size by Type (2016-2027)
10.3 Middle East & Africa CRO in Clinical Trials Market Size by Application
10.3.1 Middle East & Africa CRO in Clinical Trials Market Size by Application (2016-2021)
10.3.2 Middle East & Africa CRO in Clinical Trials Market Size by Application (2022-2027)
10.3.3 Middle East & Africa CRO in Clinical Trials Market Size by Application (2016-2027)
10.4 Middle East & Africa CRO in Clinical Trials Market Size by Country
10.4.1 Middle East & Africa CRO in Clinical Trials Market Size by Country (2016-2021)
10.4.2 Middle East & Africa CRO in Clinical Trials Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Covance (Lab. Corp.)
11.1.1 Covance (Lab. Corp.) Company Details
11.1.2 Covance (Lab. Corp.) Business Overview
11.1.3 Covance (Lab. Corp.) CRO in Clinical Trials Introduction
11.1.4 Covance (Lab. Corp.) Revenue in CRO in Clinical Trials Business (2016-2021)
11.1.5 Covance (Lab. Corp.) Recent Development
11.2 QVIA
11.2.1 QVIA Company Details
11.2.2 QVIA Business Overview
11.2.3 QVIA CRO in Clinical Trials Introduction
11.2.4 QVIA Revenue in CRO in Clinical Trials Business (2016-2021)
11.2.5 QVIA Recent Development
11.3 Syneos Health
11.3.1 Syneos Health Company Details
11.3.2 Syneos Health Business Overview
11.3.3 Syneos Health CRO in Clinical Trials Introduction
11.3.4 Syneos Health Revenue in CRO in Clinical Trials Business (2016-2021)
11.3.5 Syneos Health Recent Development
11.4 Parexel
11.4.1 Parexel Company Details
11.4.2 Parexel Business Overview
11.4.3 Parexel CRO in Clinical Trials Introduction
11.4.4 Parexel Revenue in CRO in Clinical Trials Business (2016-2021)
11.4.5 Parexel Recent Development
11.5 PRA Health Sciences
11.5.1 PRA Health Sciences Company Details
11.5.2 PRA Health Sciences Business Overview
11.5.3 PRA Health Sciences CRO in Clinical Trials Introduction
11.5.4 PRA Health Sciences Revenue in CRO in Clinical Trials Business (2016-2021)
11.5.5 PRA Health Sciences Recent Development
11.6 PPD
11.6.1 PPD Company Details
11.6.2 PPD Business Overview
11.6.3 PPD CRO in Clinical Trials Introduction
11.6.4 PPD Revenue in CRO in Clinical Trials Business (2016-2021)
11.6.5 PPD Recent Development
11.7 Charles River
11.7.1 Charles River Company Details
11.7.2 Charles River Business Overview
11.7.3 Charles River CRO in Clinical Trials Introduction
11.7.4 Charles River Revenue in CRO in Clinical Trials Business (2016-2021)
11.7.5 Charles River Recent Development
11.8 ICON
11.8.1 ICON Company Details
11.8.2 ICON Business Overview
11.8.3 ICON CRO in Clinical Trials Introduction
11.8.4 ICON Revenue in CRO in Clinical Trials Business (2016-2021)
11.8.5 ICON Recent Development
11.9 Wuxi AppTec
11.9.1 Wuxi AppTec Company Details
11.9.2 Wuxi AppTec Business Overview
11.9.3 Wuxi AppTec CRO in Clinical Trials Introduction
11.9.4 Wuxi AppTec Revenue in CRO in Clinical Trials Business (2016-2021)
11.9.5 Wuxi AppTec Recent Development
11.10 MedPace
11.10.1 MedPace Company Details
11.10.2 MedPace Business Overview
11.10.3 MedPace CRO in Clinical Trials Introduction
11.10.4 MedPace Revenue in CRO in Clinical Trials Business (2016-2021)
11.10.5 MedPace Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療IT)の最新刊レポート

本レポートと同じKEY WORD(clinical trials)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る